E. Ohman J:or Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

E. Ohman J:or Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,400	Closed	-$153K	–	468
2021 Q1	$153K	Hold	3,400	–	–	0.01%	444
2020 Q4	$192K	Hold	3,400	–	–	0.01%	415
2020 Q3	$161K	Hold	3,400	–	–	0.01%	413
2020 Q2	$200K	Hold	3,400	–	–	0.01%	396
2020 Q1	$161K	Hold	3,400	–	–	0.01%	387
2019 Q4	$205K	Buy	+3,400	New	+$203K	0.01%	411
2016 Q3	–	Sell	-2,800	Closed	-$65.2K	–	539
2016 Q2	$65.2K	Hold	2,800	–	–	0.01%	523
2016 Q1	$113K	Hold	2,800	–	–	0.02%	462
2015 Q4	$173K	Buy	+2,800	New	+$151K	0.03%	385

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

E. Ohman J:or Asset Management's IONS Position: Q2 2021 in Review

E. Ohman J:or Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 3,400 shares — an estimated $153K sold.

E. Ohman J:or Asset Management first reported a position in IONS in Q4 2015 and held it in 9 quarters. The position peaked at $205K in Q4 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

E. Ohman J:or Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
E. Ohman J:or Asset Management sold 3,400 Ionis Pharmaceuticals shares in Q2 2021, an estimated $153K.
E. Ohman J:or Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 9 quarters.
E. Ohman J:or Asset Management's Ionis Pharmaceuticals position peaked at $205K in Q4 2019.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2021, filed 5 Apr 2024.